medscape.com
Adding irinotecan to standard chemoradiotherapy for MRI-defined, locally advanced rectal cancer did not improve disease-free survival or pathologic complete response rates but increased toxicity, including diarrhea and neutropenia.
2 months ago
medscape.com
Can Romiplostim Reduce Chemotherapy Disruptions in GI Cancer?
7 months ago
medscape.com
ICI Use and Secondary Cancer Risk: Is There a Link?
8 months ago
medscape.com
A recent analysis found a much higher major infection rate in patients receiving a liberalized diet vs a neutropenic diet, suggesting a liberalized diet “is not a safe alternative.”
9 months ago
medscape.com
The FDA continues to approve new drugs and expand indications for others at a rapid pace. Here’s a summary of what happened last month.
almost 2 years ago
medscape.com
In a real-world population of patients with EGFR-mutant advanced lung cancer, overall survival was much worse in patients who would not have been eligible for the pivotal FLAURA trial.
about 2 years ago
medscape.com
GPT-4 provided highly accurate pancreatic ductal adenocarcinoma synoptic reports from original reports and outperformed GPT-3.5.
over 2 years ago
medscape.com
This new column will explore the ways in which insurance companies may dictate or restrict cancer care. Each month, oncologists and patients will share their experiences. But first, how did we get here?
over 3 years ago
medscape.com
Oncologist Rebecca Shatsky, MD, yelled at an insurance company physician during a peer-to-peer when he refused to approve a drug for her patient. Her office gave her a standing ovation.
over 3 years ago
medscape.com
Experts remain divided on the value of discarded cancer drugs but agree that ‘we
all are chipping away at this monster of cancer care costs.’
over 4 years ago
medscape.com
Many individuals who are eligible for lung cancer screening have limited or no
access to a facility that conducts such screening, not only in rural areas, but
also in urban areas.
over 4 years ago
medscape.com
Many individuals who are eligible for lung cancer screening have limited or no
access to a facility that conducts such screening, not only in rural areas, but
also in urban areas.
over 4 years ago
